跳至主要内容
临床试验/ISRCTN16919107
ISRCTN16919107已完成不适用

Clinical and laryngoscopic predictors of symptomatic response to pantoprazole magnesium in patients with newly diagnosed laryngopharyngeal reflux: a prospective study

Takeda Pharmaceutical Company Limited0 个研究点目标入组 100 人开始时间: 2016年8月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Aged 18 years and over
  • 2. Chief complaint of hoarseness, sore throat, throat burning/pain, throat clearing, voice loss, cough, excessive throat mucus, globus, or choking for at least 4 weeks in the preceding 3 months

排除标准

  • 1. Patients younger than age 18
  • 2. Patients with identifiable laryngeal pathology
  • 3. Upper respiratory tract infection in the past 4 weeks
  • 4. Identifiable allergic causes of laryngitis
  • 5. Previous laryngeal malignancy, surgery or radiotherapy
  • 6. Women of childbearing potential not using an effective contraceptive method
  • 7. Acid-suppressive therapy within the past 4 weeks
  • 8. Hypersensitivity to the active ingredient, or to any of the excipients of the product
  • 9. Patients taking HIV protease inhibitors or methotrexate

研究者

相似试验